NFC
BNTX icon

Northeast Financial Consultants’s BioNTech BNTX Stock Holding History

Northeast Financial Consultants’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,989
Closed -$216K – 281
2023
Q3 		$216K Hold
1,989
– – 0.01% 255
2023
Q2 		$215K Hold
1,989
– – 0.01% 260
2023
Q1 		$248K Hold
1,989
– – 0.02% 267
2022
Q4 		$299K Hold
1,989
– – 0.02% 244
2022
Q3 		$268K Hold
1,989
– – 0.02% 278
2022
Q2 		$297K Buy
1,989
+33
+2% +$5.04K 0.02% 257
2022
Q1 		$334K Sell
1,956
-5,969
-75% -$1M 0.02% 285
2021
Q4 		$2.04M Sell
7,925
-1,250
-14% -$342K 0.12% 89
2021
Q3 		$2.5M Buy
9,175
+1,280
+16% +$407K 0.17% 79
2021
Q2 		$1.77M Hold
7,895
– – 0.12% 107
2021
Q1 		$862K Hold
7,895
– – 0.07% 154
2020
Q4 		$644K Sell
7,895
-328
-4% -$32.2K 0.05% 169
2020
Q3 		$574K Buy
8,223
+5,115
+165% +$367K 0.05% 164
2020
Q2 		$207K Buy
+3,108
New +$155K 0.02% 265

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Northeast Financial Consultants's BNTX Position: Q4 2023 in Review

Northeast Financial Consultants sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 1,989 shares — an estimated $216K sold.

Northeast Financial Consultants first reported a position in BNTX in Q2 2020 and held it in 14 quarters. The position peaked at $2.5M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Northeast Financial Consultants reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Northeast Financial Consultants sold 1,989 BioNTech shares in Q4 2023, an estimated $216K.
  • Northeast Financial Consultants first reported a position in BioNTech in Q2 2020 and held it in 14 quarters.
  • Northeast Financial Consultants's BioNTech position peaked at $2.5M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Northeast Financial Consultants's 13F filing for Q4 2023, filed 14 Feb 2024.